Abstract

Continuous Intrathecal Drug Delivery through an implanted pump is a well-known therapeutic option for the management of chronic pain and severe disabling spasticity. To have a successful therapy, pump refills need to be performed at regular time intervals after implantation. In line with the increased applications of Hospital at Home, these refill procedures might be performed at the patient’s home. The aim of this pilot study is to evaluate the feasibility, safety, and effectiveness of intrathecal pump refill procedures at home. Twenty patients were included whereby pump refill procedures were conducted at the patient’s home. To enable contact with the hospital, a video connection was set-up. Tele-ultrasound was used as post-refill verification. All procedures were successfully performed with complete patient satisfaction. Ninety-five percent of the patients felt safe during the procedure, and 95% of the procedures felt safe according to the physician. All patients indicated that they preferred their next refill at home. The median time consumption for the physician/nurse at the patient’s home was 26 min and for the researcher at the hospital 15 min. In light of quality enhancement programs and personalized care, it is important to continue urgent pain management procedures in a safe way, even during a pandemic.

Highlights

  • The coronavirus disease 2019 (COVID-19) outbreak, declared as a pandemic by the World Health Organization (WHO) on 11 March 2020 [1], is still a serious global public health concern

  • To assure continuity of care for chronic patients during the COVID-19 pandemic, telehealth has been suggested, which is defined as the delivery and facilitation of health and health-related services including medical care, education, health information services, and self-care via telecommunications and digital communication technologies, including digital communication technology, live video conferencing, remote patient monitoring or mobile health apps [4,5]

  • 20 consecutive patients were included in this prospective pilot study

Read more

Summary

Introduction

The coronavirus disease 2019 (COVID-19) outbreak, declared as a pandemic by the World Health Organization (WHO) on 11 March 2020 [1], is still a serious global public health concern. This disease is caused by a novel coronavirus which was first discovered in Wuhan, China in December 2019 and later spread rapidly throughout the world [2]. To assure continuity of care for chronic patients during the COVID-19 pandemic, telehealth has been suggested, which is defined as the delivery and facilitation of health and health-related services including medical care, education, health information services, and self-care via telecommunications and digital communication technologies, including digital communication technology, live video conferencing, remote patient monitoring or mobile health apps [4,5]. Telemedicine, i.e., the practice of medicine via remote means [5], has already been successfully applied in chronic pain management [6,7,8,9,10]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call